Recent Merkin Prize coverage highlights Michael Merzenich's neuroplasticity research and examines new clinical data from BrainHQ cognitive training trials.
September 15, 2026 news coverage centers on neuroscientist Michael Merzenich receiving the Merkin Prize in Biomedical Technology. The award announcement recognized Merzenich and his co-inventors for their role in developing the cochlear implant.
Merzenich published research in the 1970s arguing that the adult brain remains capable of physical and functional change throughout life. This idea challenged the prevailing view at the time. Many scientists believed that meaningful brain plasticity was restricted strictly to childhood. Merzenich helped establish the widely accepted view that adult brains retain the capacity to adapt.
The cochlear implant provided a practical demonstration of his early neuroplasticity theory. Merzenich helped solve how to connect an artificial cochlea to the brain using only eight connections. The natural cochlea relies on thousands of connections to process sound. The success of the implant relied on the brain’s inherent ability to reorganize around new sensory input.
This reorganization process requires the brain to interpret unfamiliar electrical signals as meaningful sounds. The human auditory system adapts to these new inputs by altering its physical pathways. These functional changes allow users to process speech and ambient noise effectively. The findings transformed medical approaches to sensory restoration and cognitive rehabilitation.
The award recognizes a technology that has advanced human health. The announcement says cochlear implants have restored hearing to more than one million people with deafness. Initial expectations suggested that patient adaptation would take months. However, early cochlear-implant patients were able to converse within days.
Following his work on invasive procedures, Merzenich shifted his focus to sensory-based training programs. He designed software intended to individualize difficulty and progressively challenge users. The goal was to engage neurochemical changes associated with learning. He co-founded Posit Science in 2003 to distribute these digital programs.
BrainHQ evolved directly from this foundation in applied neuroplasticity. The award coverage notes that Posit Science claims a massive research output. Their announcement says the BrainHQ-related research program has generated more than 300 peer-reviewed studies. These studies reportedly cover aging, brain injury, mental illness and neurodegenerative disease.
Because this figure appears in a company-distributed announcement, it requires careful reading. The announcement is not accompanied by a complete bibliography. It should be presented as a reported research-program tally rather than as an independently audited count. A company-linked source does not provide the same validation as a third-party clinical review.
Three recent studies highlight how structured cognitive training interacts with human brain function. The INHANCE randomized trial evaluated older adults who completed 10 weeks of BrainHQ training. Reports on the study say participants underwent PET imaging before and after the intervention. The imaging found increased cholinergic terminal density in key frontal regions.
This increased density was not seen in the untrained control groups. Cholinergic activity involves acetylcholine, a vital neurotransmitter for attention and neuroplasticity. Acetylcholine levels are known to decline with age and fall substantially in Alzheimer’s disease. The INHANCE finding demonstrates a physiological change in a specific brain system.
The ACTIVE study provides long-term observational data on dementia diagnoses and cognitive training. This study originally enrolled 2,802 adults aged 65 and older between 1998 and 1999. Researchers compared memory training, reasoning training and speed-of-processing training. A 20-year follow-up examined the rates of claims-based dementia diagnoses using Medicare records.
The ACTIVE result is particularly relevant because the original participants were at least 65 years old. Participants assigned to speed-of-processing training who completed at least one booster session showed a notable outcome. This specific group had a hazard ratio of 0.75 for diagnosed Alzheimer’s disease and related dementias. This corresponds to a 25 percent lower relative rate than the untrained control group.
A relative risk reduction provides helpful statistical insight without representing an individual person's absolute risk. The ENACT randomized controlled trial also reported biological findings following cognitive training. Reports on ENACT say participants showed favourable changes in a blood beta-amyloid biomarker ratio. The specific ratio measured was Aβ42/Aβ40, which is commonly associated with Alzheimer’s pathology.
The BrainHQ account says the change was observed after approximately 20 hours of specialized training. These findings offer an interesting perspective on how behavioral interventions might influence blood biomarkers. However, a BrainHQ report notes that the observed beta-amyloid change occurred in men but not women. This reported sex difference requires further independent confirmation before drawing broad clinical conclusions.
Clinical trials often reveal that biological markers respond differently across distinct demographic groups. Understanding these variations helps researchers develop more targeted interventions for older adults. Evaluating these nuances is a critical part of translating laboratory findings into practical guidance. Readers can learn more about interpreting clinical research in our brain aging and neuroplasticity articles.
These findings provide encouraging data on brain plasticity, but they require careful interpretation. Consumers should always evaluate cognitive training programs critically. Evaluating whether a program publishes peer-reviewed results and reports control groups is a vital step.
The long-term ACTIVE result was highly specific to one intervention and required consistent reinforcement. Speed training without booster sessions had a hazard ratio of 1.01. That subgroup did not show the same protective association as the boosted group. Furthermore, memory and reasoning training did not show a main effect on dementia risk in the ACTIVE study.
Readers should not assume that every generic puzzle reproduces the tested intervention. Biological markers also have clear limitations in clinical research contexts. The ENACT result involves a blood beta-amyloid ratio, while the INHANCE study measured cholinergic imaging changes. Neither finding proves that a short course of training prevents Alzheimer’s disease.
The broader brain-health field is also producing evidence on non-training factors. A recent synthesis reported that higher physical-activity levels were associated with lower risks of all-cause dementia and Alzheimer’s disease. This evidence was observational and heterogeneous, but it supports a broad cognitive-longevity strategy. The available evidence does not justify replacing physical activity, sleep, vascular-risk management or medical evaluation with an app.
Managing vascular risk factors and staying socially engaged remain fundamental practices. You can read more about building resilient daily habits in our lifestyle and brain resilience articles. Structured brain training can supplement a healthy routine, but physical movement remains independently associated with lower dementia risk.
Sensory health remains a vital part of protecting your memory as you age. Merzenich’s early work on cochlear implants shows that sensory input and brain adaptation are closely connected. The brain requires clear signals from the environment to maintain its functional networks. Addressing hearing loss is a critical step in preserving cognitive function.
Adults concerned about cognitive decline should not overlook a standard hearing assessment. Unmanaged hearing loss forces the brain to expend extra energy processing degraded sounds. This strain can divert resources away from memory encoding and higher cognitive tasks. Seeking proper hearing care may offer significant benefits for long-term brain health.
The Merkin Prize coverage highlights how scientific understanding of the aging brain has evolved. Research consistently confirms that adult brains retain the capacity to change and adapt. Targeted training protocols can produce measurable physiological signals and long-term observational benefits. Evaluating these tools objectively allows you to support your health safely.
Adults over 60 can focus on structured practice with clear progression metrics. Programs that publish peer-reviewed results and define booster requirements offer more transparent evidence. The strongest results come from highly specific interventions combined with healthy daily habits. You can find more practical guidance in our memory and focus articles.
Evaluating which specific cognitive training programs deserve your time requires moving beyond initial study announcements to build practical daily routines. Uncertainty about which everyday habits may support cognitive health often makes long-term planning difficult, and FitBrainLab translates this complex research so you can focus on actionable steps.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
